Endometrial Cancer Stem Cells: Where Do We Stand and Where Should We Go?
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Endometrial Cancer Stem Cells: Where Do We Stand and Where Should We Go?
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 6, Pages 3412
Publisher
MDPI AG
Online
2022-03-22
DOI
10.3390/ijms23063412
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanopore Sequencing Reveals Global Transcriptome Signatures of Mitochondrial and Ribosomal Gene Expressions in Various Human Cancer Stem-like Cell Populations
- (2021) Kaya E. Witte et al. Cancers
- IL-37bΔ1-45 suppresses the migration and invasion of endometrial cancer cells by targeting the Rac1/NF-κB/MMP2 signal pathway
- (2021) Xishuang Wang et al. LABORATORY INVESTIGATION
- Novel Primary Human Cancer Stem-Like Cell Populations from Non-Small Cell Lung Cancer: Inhibition of Cell Survival by Targeting NF-κB and MYC Signaling
- (2021) Beatrice A. Windmöller et al. Cells
- Pembrolizumab and lenvatinib versus carboplatin and paclitaxel as first-line therapy for advanced or recurrent endometrial cancer: A Markov analysis
- (2021) Sarah A. Ackroyd et al. GYNECOLOGIC ONCOLOGY
- Health-related quality of life (HRQoL) in advanced endometrial cancer (aEC) patients (pts) treated with lenvatinib plus pembrolizumab or treatment of physician’s choice (TPC).
- (2021) Domenica Lorusso et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunotherapy in endometrial cancer: rationale, practice and perspectives
- (2021) Wenyu Cao et al. Biomarker Research
- High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer
- (2020) Hilde Engerud et al. GYNECOLOGIC ONCOLOGY
- Knockdown of SLCO4C1 inhibits cell proliferation and metastasis in endometrial cancer through inactivating the PI3K/Akt signaling pathway
- (2020) Xiang Hu et al. ONCOLOGY REPORTS
- PD-L1 is overexpressed on breast cancer stem cells through notch3/mTOR axis
- (2020) Fatmah A. Mansour et al. OncoImmunology
- Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer
- (2020) Carlos Casas-Arozamena et al. Journal of Clinical Medicine
- Cancer immunotherapy: Pros, cons and beyond
- (2020) Shuzhen Tan et al. BIOMEDICINE & PHARMACOTHERAPY
- The emerging role of Wnt5a in the promotion of a pro-inflammatory and immunosuppressive tumor microenvironment
- (2020) Pablo Lopez-Bergami et al. CANCER AND METASTASIS REVIEWS
- MicroRNA‑16 inhibits endometrial stromal cell migration and invasion through suppression of the inhibitor of nuclear factor‑κB kinase subunit β/nuclear factor‑κB pathway
- (2020) Xiaoping Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
- (2020) Vicky Makker et al. JOURNAL OF CLINICAL ONCOLOGY
- ENGOT-en9/LEAP-001: A phase III study of first-line pembrolizumab plus lenvatinib versus chemotherapy in advanced or recurrent endometrial cancer.
- (2020) Christian Marth et al. JOURNAL OF CLINICAL ONCOLOGY
- ENGOT-EN6/NSGO-RUBY: A phase III, randomized, double-blind, multicenter study of dostarlimab + carboplatin-paclitaxel versus placebo + carboplatin-paclitaxel in recurrent or primary advanced endometrial cancer (EC).
- (2020) Mansoor Raza Mirza et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic and Clinicopathological Role of PD-L1 in Endometrial Cancer: A Meta-Analysis
- (2020) Ling Lu et al. Frontiers in Oncology
- Inhibition of Lnc-OC1 Induced Cell Apoptosis and Decreased Cell Viability by Releasing miR-34a and Inhibiting PD-L1 in Endometrial Carcinoma
- (2020) Yun Liu et al. Reproductive Sciences
- Ubiquitin C-Terminal Hydrolase L5 (UCHL5) Accelerates the Growth of Endometrial Cancer via Activating the Wnt/β-Catenin Signaling Pathway
- (2020) Da Liu et al. Frontiers in Oncology
- Energy metabolism in cancer stem cells
- (2020) Xuan Zhu et al. World Journal of Stem Cells
- Enolase 1 regulates stem cell-like properties in gastric cancer cells by stimulating glycolysis
- (2020) Ting Yang et al. Cell Death & Disease
- Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy
- (2020) Shumei Kato et al. Nature Communications
- Hypoxia induces an endometrial cancer stem-like cell phenotype via HIF-dependent demethylation of SOX2 mRNA
- (2020) Guofang Chen et al. Oncogenesis
- Isolation and Characterization of Two Novel Colorectal Cancer Cell Lines, Containing a Subpopulation with Potential Stem-Like Properties: Treatment Options by MYC/NMYC Inhibition
- (2020) Jan Schulte am Esch et al. Cancers
- The Situation of Cervical Cancers in the Context of Female Genital Cancer Clustering and Burden of Disease in Arad County, Romania
- (2019) Ana-Liana Tataru et al. Journal of Clinical Medicine
- c‑Myc maintains the self‑renewal and chemoresistance properties of colon cancer stem cells
- (2019) Huan‑Le Zhang et al. Oncology Letters
- X chromosome-linked long noncoding RNA lnc-XLEC1 regulates c-Myc -dependent cell growth by collaborating with MBP-1 in endometrial cancer
- (2019) Fang Li et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting Endometrial Cancer Stem Cell Activity with Metformin Is Inhibited by Patient-Derived Adipocyte-Secreted Factors
- (2019) Sarah J. Kitson et al. Cancers
- A Role for NF-κB in Organ Specific Cancer and Cancer Stem Cells
- (2019) Christian Kaltschmidt et al. Cancers
- Aurora-A Induces Chemoresistance Through Activation of the AKT/mTOR Pathway in Endometrial Cancer
- (2019) Jun Wu et al. Frontiers in Oncology
- MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways
- (2019) Blanca Majem et al. ONCOGENE
- Metformin suppresses cancer cell growth in endometrial carcinoma by inhibiting PD-L1
- (2019) Jing Xue et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- ALDH-Dependent Glycolytic Activation Mediates Stemness and Paclitaxel Resistance in Patient-Derived Spheroid Models of Uterine Endometrial Cancer
- (2019) Yutaro Mori et al. Stem Cell Reports
- Hypoxia and hyperglycaemia determine why some endometrial tumours fail to respond to metformin
- (2019) Vanitha N. Sivalingam et al. BRITISH JOURNAL OF CANCER
- PRMT6 promotes endometrial cancer via AKT/mTOR signaling and indicates poor prognosis
- (2019) Nan Jiang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways
- (2019) María José Besso et al. Frontiers in Oncology
- Effect of metformin use on the risk and prognosis of endometrial cancer: a systematic review and meta-analysis
- (2018) Danxia Chu et al. BMC CANCER
- STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
- (2018) Jung-Mao Hsu et al. Nature Communications
- Correlation of MACC1/c-Myc Expression in Endometrial Carcinoma with Clinical/Pathological Features or Prognosis
- (2018) Qinghua Zhang et al. MEDICAL SCIENCE MONITOR
- MicroRNA‑423 promotes proliferation, migration and invasion and induces chemoresistance of endometrial cancer cells
- (2018) Jie Li et al. Experimental and Therapeutic Medicine
- MicroRNA-373 promotes the development of endometrial cancer by targeting LATS2 and activating the Wnt/β-Catenin pathway
- (2018) Yan Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Endometrial Cancer Spheres Show Cancer Stem Cells Phenotype and Preference for Oxidative Metabolism
- (2018) Maria João Carvalho et al. PATHOLOGY & ONCOLOGY RESEARCH
- Targeting cancer stem cell signature gene SMOC-2 Overcomes chemoresistance and inhibits cell proliferation of endometrial carcinoma
- (2018) Huan Lu et al. EBioMedicine
- A medicinal chemistry perspective on salinomycin as a potent anticancer and anti-CSCs agent
- (2018) Michał Antoszczak EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Molecular approaches for classifying endometrial carcinoma
- (2017) Josep M Piulats et al. GYNECOLOGIC ONCOLOGY
- PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation
- (2017) Sheema Almozyan et al. INTERNATIONAL JOURNAL OF CANCER
- Isolation of Stem-Like Cancer Cells in Primary Endometrial Cancer Using Cell Surface Markers CD133 and CXCR4
- (2017) Yi Sun et al. Translational Oncology
- Role of metformin in inhibiting estrogen-induced proliferation and regulating ERα and ERβ expression in human endometrial cancer cells
- (2017) Jingbo Zhang et al. Oncology Letters
- Peroxiredoxin 3 maintains the survival of endometrial cancer stem cells by regulating oxidative stress
- (2017) In-Sung Song et al. Oncotarget
- Expression of CD133 in endometrial cancer cells and its implications
- (2017) Dah-Ching Ding et al. Journal of Cancer
- HMGA1 facilitates tumor progression through regulating Wnt/β-catenin pathway in endometrial cancer
- (2016) Xiuxia Han et al. BIOMEDICINE & PHARMACOTHERAPY
- Hallmarks of cancer stem cell metabolism
- (2016) Patricia Sancho et al. BRITISH JOURNAL OF CANCER
- Blocking NOTCH pathway can enhance the effect of EGFR inhibitor through targeting CD133+ endometrial cancer cells
- (2016) Chao Shang et al. CANCER BIOLOGY & THERAPY
- Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines
- (2016) Ido Laskov et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Effects of estradiol on VEGF and bFGF by Akt in endometrial cancer cells are mediated through the NF-κB pathway
- (2016) Jieqing Zhang et al. ONCOLOGY REPORTS
- RelB/NF-κB links cell cycle transition and apoptosis to endometrioid adenocarcinoma tumorigenesis
- (2016) Qiu-Lin Ge et al. Cell Death & Disease
- JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer
- (2016) Haifeng Qiu et al. Oncotarget
- Metformin in Cancer Treatment and Prevention
- (2015) Daniel R. Morales et al. Annual Review of Medicine
- Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor
- (2015) Toshio Nishimura et al. BMC CANCER
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor- B to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
- (2015) J. Peng et al. CANCER RESEARCH
- MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells
- (2015) Patricia Sancho et al. Cell Metabolism
- Cancer stem cell targeted therapy: progress amid controversies
- (2015) Tao Wang et al. Oncotarget
- Enolase-1 is a therapeutic target in endometrial carcinoma
- (2015) Mengyang Zhao et al. Oncotarget
- Hedgehog Signaling in the Maintenance of Cancer Stem Cells
- (2015) Catherine Cochrane et al. Cancers
- SALL4 as an Epithelial-Mesenchymal Transition and Drug Resistance Inducer through the Regulation of c-Myc in Endometrial Cancer
- (2015) Lei Liu et al. PLoS One
- MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells
- (2015) Yosuke Konno et al. Oncotarget
- Metformin impairs growth of endometrial cancer cells via cell cycle arrest and concomitant autophagy and apoptosis
- (2014) Akimasa Takahashi et al. Cancer Cell International
- MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins
- (2014) Yongtao Gao et al. FEBS LETTERS
- Hypoxia as a biomarker for radioresistant cancer stem cells
- (2014) Claudia Peitzsch et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer
- (2014) Peixin Dong et al. Journal of Translational Medicine
- Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer
- (2014) Lorena Alonso-Alconada et al. Molecular Cancer
- Obesity and Age at Diagnosis of Endometrial Cancer
- (2014) Nicole S. Nevadunsky et al. OBSTETRICS AND GYNECOLOGY
- Artemisinin triggers a G1 cell cycle arrest of human Ishikawa endometrial cancer cells and inhibits cyclin-dependent kinase-4 promoter activity and expression by disrupting nuclear factor-κB transcriptional signaling
- (2013) Kalvin Q. Tran et al. ANTI-CANCER DRUGS
- Wnt signaling in stem and cancer stem cells
- (2013) Jane D Holland et al. CURRENT OPINION IN CELL BIOLOGY
- Tamoxifen Represses miR-200 MicroRNAs and Promotes Epithelial-to-Mesenchymal Transition by Up-Regulating c-Myc in Endometrial Carcinoma Cell Lines
- (2013) Jiu-Xu Bai et al. ENDOCRINOLOGY
- The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells
- (2013) Soshi Kusunoki et al. GYNECOLOGIC ONCOLOGY
- Down-regulated expression of Notch signaling molecules in human endometrial cancer
- (2013) Violeta Jonusiene et al. MEDICAL ONCOLOGY
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Improved surgical safety after laparoscopic compared to open surgery for apparent early stage endometrial cancer: Results from a randomised controlled trial
- (2012) Andreas Obermair et al. EUROPEAN JOURNAL OF CANCER
- Immunohistochemical features of post-radiation vaginal recurrences of endometrioid carcinomas of the endometrium: role for proteins involved in resistance to apoptosis and hypoxia
- (2012) Maria Santacana et al. HISTOPATHOLOGY
- Prognostic significance of Notch signalling molecules and their involvement in the invasiveness of endometrial carcinoma cells
- (2012) Yuko Mitsuhashi et al. HISTOPATHOLOGY
- Clonal evolution in cancer
- (2012) Mel Greaves et al. NATURE
- Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization
- (2011) Kwang-Youn Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group
- (2011) Amit M. Oza et al. JOURNAL OF CLINICAL ONCOLOGY
- Nuclear factor-κB2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1α independent manner
- (2011) Andree Yeramian et al. LABORATORY INVESTIGATION
- Expression of HER-2 affects patient survival and paclitaxel sensitivity in endometrial cancer
- (2010) N Mori et al. BRITISH JOURNAL OF CANCER
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Functional analyses of the cancer stem cell-like properties of human endometrial tumor initiating cells
- (2010) Anne M. Friel et al. CELL CYCLE
- Evidence for Cancer Stem Cells in Human Endometrial Carcinoma
- (2009) S. A. Hubbard et al. CANCER RESEARCH
- Cells with Characteristics of Cancer Stem/Progenitor Cells Express the CD133 Antigen in Human Endometrial Tumors
- (2009) S. Rutella et al. CLINICAL CANCER RESEARCH
- Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer
- (2009) R.A. de Jong et al. GYNECOLOGIC ONCOLOGY
- Stem cell concepts renew cancer research
- (2008) J. E. Dick BLOOD
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Phase II Study of Erlotinib in Recurrent or Metastatic Endometrial Cancer: NCIC IND-148
- (2008) Amit M. Oza et al. JOURNAL OF CLINICAL ONCOLOGY
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
- (2008) Andrew G Renehan et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started